Total Payments
$2,778
2024 Payments
$1,022
Companies
16
Transactions
170
Medicare Patients
115
Medicare Billing
$11,130
Payment Breakdown by Category
Food & Beverage$2,544 (91.6%)
Education$233.85 (8.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,544 | 166 | 91.6% |
| Education | $233.85 | 4 | 8.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $508.43 | 27 | $0 (2024) |
| ABBVIE INC. | $480.11 | 44 | $0 (2024) |
| Alkermes, Inc. | $289.97 | 16 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $275.20 | 13 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $261.88 | 14 | $0 (2024) |
| ITI, Inc. | $248.05 | 18 | $0 (2023) |
| Supernus Pharmaceuticals, Inc. | $179.23 | 11 | $0 (2024) |
| Lundbeck LLC | $139.04 | 7 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $92.95 | 4 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $84.86 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,022 | 54 | Teva Pharmaceuticals USA, Inc. ($227.17) |
| 2023 | $734.03 | 42 | ABBVIE INC. ($198.05) |
| 2022 | $1,021 | 74 | ITI, Inc. ($200.69) |
All Payment Transactions
170 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $31.26 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 12/06/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: PSYCHIATRY | ||||||
| 12/02/2024 | Lundbeck LLC | ABILIFY MAINTENA (Drug) | Food and Beverage | Cash or cash equivalent | $14.42 | General |
| Category: PSYCHIATRY | ||||||
| 11/22/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $19.69 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $23.17 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 11/06/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 11/01/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: Neuropsychiatry | ||||||
| 10/29/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $10.85 | General |
| Category: Central Nervous System | ||||||
| 10/28/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $14.41 | General |
| Category: PSYCHIATRY | ||||||
| 10/26/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $6.57 | General |
| Category: Neurology | ||||||
| 10/23/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: Opioid Use Disorder | ||||||
| 10/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 09/25/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: Neuropsychiatry | ||||||
| 09/24/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: PSYCHIATRY | ||||||
| 09/20/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $27.85 | General |
| Category: Neuroscience | ||||||
| 09/10/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: CNS | ||||||
| 09/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.81 | General |
| Category: NEUROSCIENCE | ||||||
| 09/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.07 | General |
| Category: NEUROSCIENCE | ||||||
| 09/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: NEUROSCIENCE | ||||||
| 08/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.56 | General |
| Category: NEUROSCIENCE | ||||||
| 08/20/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: Neurology | ||||||
| 08/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.31 | General |
| Category: NEUROSCIENCE | ||||||
| 08/14/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 39 | 101 | $7,375 | $4,297 |
| 2022 | 2 | 76 | 150 | $9,861 | $6,834 |
Total Patients
115
Total Services
251
Medicare Billing
$11,130
Procedure Codes
5
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 17 | 48 | $4,070 | $2,745 | 67.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 22 | 53 | $3,305 | $1,551 | 46.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 43 | 102 | $7,047 | $4,913 | 69.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 18 | 26 | $1,582 | $1,077 | 68.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 15 | 22 | $1,232 | $842.96 | 68.4% |
About Rachel Maynard
Rachel Maynard is a Registered Nurse healthcare provider based in Louisa, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/21/2022. The National Provider Identifier (NPI) number assigned to this provider is 1093467052.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Rachel Maynard has received a total of $2,778 in payments from pharmaceutical and medical device companies, with $1,022 received in 2024. These payments were reported across 170 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($2,544).
As a Medicare-enrolled provider, Maynard has provided services to 115 Medicare beneficiaries, totaling 251 services with total Medicare billing of $11,130. Data is available for 2 years (2022–2023), covering 5 distinct procedure/service records.
Ad
Practice Information
- Specialty Registered Nurse
- Other Specialties Psychiatric/Mental Health
- Location Louisa, KY
- Active Since 01/21/2022
- Last Updated 08/14/2025
- Taxonomy Code 163W00000X
- Entity Type Individual
- NPI Number 1093467052
Products in Payments
- VRAYLAR (Drug) $480.11
- ARISTADA (Drug) $273.47
- CAPLYTA (Drug) $267.45
- INVEGA SUSTENNA (Drug) $224.85
- REXULTI (Drug) $223.46
- AUSTEDO (Drug) $207.53
- ABILIFY MAINTENA (Drug) $155.08
- QELBREE (Drug) $116.66
- Austedo XR (Drug) $114.67
- HETLIOZ (Drug) $92.95
- INGREZZA (Drug) $84.86
- UZEDY (Drug) $79.73
- Qelbree (Drug) $62.57
- Lucemyra (Drug) $52.68
- SPRAVATO (Drug) $39.99
- Auvelity (Drug) $39.03
- SUBLOCADE (Drug) $36.78
- BRIXADI (Drug) $31.22
- ABILIFY ASIMTUFII (Drug) $22.38
- COBENFY (Drug) $19.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Registered Nurse Doctors in Louisa
Jessica Maupin, Pmhnp-Bc, PMHNP-BC
Registered Nurse — Payments: $973.86
Registered Nurse $973.86
Sheila Short, Aprn, APRN
Registered Nurse — Payments: $197.06
Registered Nurse $197.06
Rodney Brown, Np, NP
Registered Nurse — Payments: $106.43
Registered Nurse $106.43
Amy Yoho, Rn, RN
Registered Nurse
Registered Nurse
Shirley Chaffin
Registered Nurse
Registered Nurse
Teehia Newsome
Registered Nurse
Registered Nurse